Sanctuary Advisors LLC Has $4.07 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Sanctuary Advisors LLC raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.2% during the fourth quarter, Holdings Channel reports. The firm owned 41,496 shares of the medical device company’s stock after buying an additional 887 shares during the period. Sanctuary Advisors LLC’s holdings in Cooper Companies were worth $4,071,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Figure 8 Investment Strategies LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $1,360,000. Buckhead Capital Management LLC raised its stake in shares of Cooper Companies by 0.3% in the fourth quarter. Buckhead Capital Management LLC now owns 48,120 shares of the medical device company’s stock valued at $4,424,000 after acquiring an additional 152 shares during the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $691,000. Entropy Technologies LP bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $248,000. Finally, Empowered Funds LLC raised its stake in shares of Cooper Companies by 15.2% in the fourth quarter. Empowered Funds LLC now owns 3,556 shares of the medical device company’s stock valued at $327,000 after acquiring an additional 470 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

COO has been the subject of a number of research analyst reports. Wells Fargo & Company lifted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Morgan Stanley dropped their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Finally, StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $88.48 on Friday. The firm has a fifty day moving average of $92.94 and a two-hundred day moving average of $99.55. The stock has a market capitalization of $17.66 billion, a price-to-earnings ratio of 45.37, a PEG ratio of 2.19 and a beta of 1.00. The Cooper Companies, Inc. has a 52 week low of $84.76 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.87 EPS. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.